Santen Pharmaceutical News

Santen Pharmaceutical: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.

Jun 25 04:00 ET

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Jun 13 21:43 ET

Santen Pharmaceutical: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Jun 6 00:24 ET

Santen Pharmaceutical: Notice regarding the status of share buybacks

Jun 3 03:00 ET

Santen Pharmaceutical: Notice Concerning Decisions on Matters Relating to Repurchase of Treasury Shares

May 9 02:00 ET

Santen Pharmaceutical: Mass Ownership Report

Apr 22 02:27 ET

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Apr 14 22:16 ET

Santen Pharmaceutical: Notice regarding status and termination of share repurchases

Mar 25 03:00 ET

Santen Pharmaceutical: Change Report (Stock Certificates Subject to Special Cases, etc.)

Mar 18 02:36 ET

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Mar 15 01:49 ET

Santen Pharmaceutical: Notice Concerning Status of Share Repurchase

Mar 1 02:00 ET

Santen Pharmaceutical: Treasury Stock Purchase Status Report (based on Section 24-6 (1) of the Act)

Feb 14 23:25 ET

Santen Pharmaceutical: Notice regarding the status of share buybacks

Feb 1 02:00 ET

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Jan 14 20:37 ET

Santen Pharmaceutical: Notice regarding the status of treasury stock repurchases

Jan 5 02:00 ET

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Dec 14, 2023 23:18 ET

Santen Pharmaceutical: Notice regarding the status of share buybacks

Dec 1, 2023 02:00 ET

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Nov 15, 2023 02:40 ET

Santen Pharmaceutical: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Nov 6, 2023 19:43 ET

Santen Pharmaceutical: Notice regarding the status of share buybacks

Nov 1, 2023 03:00 ET